0000899243-19-006734.txt : 20190307
0000899243-19-006734.hdr.sgml : 20190307
20190307173027
ACCESSION NUMBER: 0000899243-19-006734
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190305
FILED AS OF DATE: 20190307
DATE AS OF CHANGE: 20190307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McMullin David
CENTRAL INDEX KEY: 0001738662
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36332
FILM NUMBER: 19666860
MAIL ADDRESS:
STREET 1: C/O ALDEYRA THERAPEUTICS, INC.
STREET 2: 131 HARTWELL AVENUE, SUITE 320
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aldeyra Therapeutics, Inc.
CENTRAL INDEX KEY: 0001341235
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 131 HARTWELL AVENUE
STREET 2: SUITE 320
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-761-4904
MAIL ADDRESS:
STREET 1: 131 HARTWELL AVENUE
STREET 2: SUITE 320
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: Aldexa Therapeutics, Inc.
DATE OF NAME CHANGE: 20130102
FORMER COMPANY:
FORMER CONFORMED NAME: Neuron Systems Inc
DATE OF NAME CHANGE: 20051012
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-05
0
0001341235
Aldeyra Therapeutics, Inc.
ALDX
0001738662
McMullin David
C/O ALDEYRA THERAPEUTICS, INC.
131 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Commercial Officer
Employee Stock Option (Right to Buy)
8.05
2019-03-05
4
A
0
45212
0.00
A
2029-03-04
Common Stock
45212
45212
D
The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2019.
/s/ David McMullin
2019-03-07